Delivery Order SPE2DX22D0049-SPE2D825FA9PP
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,094.70 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was competitively procured with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,379.98 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,251.31 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and is performing work at its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,307.41 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply delivery. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $862,497.87 to AmerisourceBergen Drug Corp on July 26, 2025, for pharmaceutical and medical supply procurement. The contract, which is firm fixed price with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,367.28 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract issued to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,316.11 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order was placed under...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9PPDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,257.70 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract follows a competitive procurement process, consistent with AmerisourceBergen's established track record of fulfilling federal pharmaceutical and medical supply requirements across the military healthcare system. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support has indicated plans to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions with multiple contractors, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 8/4/25 |